Allogene Therapeutics' Series A Round

Allogene Therapeutics raised a round of funding on April 04, 2018.

Allogene Therapeutics is a biotechnology company with a mission to catalyze the next revolution in cancer treatment through the development of allogeneic chimeric antigen receptor T-cell (CAR T) thera…

Articles about Allogene Therapeutics' Series A Round: